Inventiva (IVA) Asset Utilization Ratio (2021)

Inventiva's (IVA) quarterly Asset Utilization Ratio came in at 0.0 in Q2 2021.

Inventiva (IVA) Asset Utilization Ratio (2021) Analysis & Trends

Inventiva's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.0 for Q2 2021.

On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q2 2021; TTM through Jun 2021 was 0.0, a N/A change from a year earlier, with the FY2025 full-year figure at 0.02, down 83.96% from the prior year.
Asset Utilization Ratio steadied at 0.0 in Q2 2021 per IVA's latest filing.
Across five years, Asset Utilization Ratio topped out at 0.0 in Q2 2021 and bottomed at 0.0 in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.69
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.37
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Inventiva	842.48 Mn	842.48 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	0.00